Trial Information
Genetic Susceptibility to Renal Cell Carcinoma
Inclusion Criteria:
- Adult patients of any ethnicity or sex, who have a been diagnosed with possible Renal
Cell Carcinoma within the past year.
Exclusion Criteria:
- Must not have received chemotherapy, biological therapy or radiation therapy in the 6
months preceding enrollment will
- Must not have had RCC, or metastatic RCC,
- Must not have had a renal transplantation
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Seth P. Lerner, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Baylor College of Medicine
Authority:
United States: Institutional Review Board
Study ID:
H-17150
NCT ID:
NCT00854022
Start Date:
July 2008
Completion Date:
July 2014
Related Keywords:
- Renal Cell Carcinoma
- Carcinoma
- Carcinoma, Renal Cell
- Disease Susceptibility
Name | Location |
MD Anderson Cancer Center |
Houston, Texas 77030-4096 |